Investigating HIV-1 infection using rhesus macaques
Official title: NHP Core
Funded at Beth Israel Deaconess Medical Center · NIH-11084517 · Data updated 2026-11-12
This study is looking at how HIV-1 affects rhesus macaques to help us learn more about the virus and find better treatments, all while making sure the animals are well cared for.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | July 11, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $327,430 |
| NIH project number | 5P01AI177687-03 |
| Project ID | NIH-11084517 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals interested in the development of HIV-1 treatments and vaccines, particularly those affected by or at risk for HIV.
✕Less likely to help
Patients who are not affected by HIV or do not have a vested interest in HIV research may not benefit from this research.
What this research studies
This research focuses on using rhesus macaques as an animal model to study HIV-1 infection. The project aims to provide the necessary infrastructure, expertise, and resources to conduct complex in vivo studies, including vaccine research. The team will ensure high standards of animal care and compliance with clinical practices while collecting and analyzing blood and tissue samples. The goal is to enhance our understanding of HIV-1 and improve potential treatment strategies.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in HIV-1 treatment and vaccine development.
How similar studies have gone: Previous research using similar animal models has shown promise in understanding HIV-1 and developing effective treatments.
Where this research is happening
-
Beth Israel Deaconess Medical Center
Boston, United States Active
Researchers
- Principal investigator: Barouch, Dan H. — Beth Israel Deaconess Medical Center
- Study coordinator: Barouch, Dan H.
Related research
Other NIH-funded projects on the same topics.
-
SATURN MRI ancillary study: statins after intracerebral hemorrhage and brain MRI markers
This study looks at what happens to brain MRI markers and health outcomes when people with a specific type of brain bleed continue or stop taking statins.
-
Statin use after brain bleed MRI study in ICH patients (SATURN MRI) Ancillary Study
This project tests whether continuing or stopping statin therapy after an intracerebral hemorrhage affects brain changes seen on MRI and related health outcomes in people with lobar ICH.
-
Statin use after brain bleed: SATURN MRI ancillary study
This project tests whether continuing statin medicines after a brain bleed (lobar intracerebral hemorrhage) affects new brain blood vessel findings and long-term health.
-
XenCAT: Single Cell Atlas for Xenopus
Aims to map gene activity at the single-cell level in Xenopus to help understand how cells develop and how this relates to human disease.
-
Statin use after lobar intracerebral hemorrhage
This trial compares continuing versus stopping statins in people who had a lobar intracerebral hemorrhage to see how that affects repeat brain bleeds, strokes, heart attacks, and recovery over two years.
-
Statin use after lobar brain hemorrhage
This trial compares stopping versus continuing statin medicine in people who had a lobar brain bleed to learn effects on repeat bleeding and future heart or stroke events.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.